STOCK TITAN

Procore (PCOR) director Hovsepian awarded 2,330 RSUs, holds 9,527 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HOVSEPIAN RONALD W reported acquisition or exercise transactions in this Form 4 filing.

PROCORE TECHNOLOGIES, INC. director Ronald W. Hovsepian received 2,330 shares of common stock in the form of restricted stock units as a compensation grant. The RSUs vest in full at the company’s 2027 annual meeting of stockholders, subject to his continued board service, bringing his direct holdings to 9,527 shares.

Positive

  • None.

Negative

  • None.
Insider HOVSEPIAN RONALD W
Role null
Type Security Shares Price Value
Grant/Award Common Stock 2,330 $0.00 --
Holdings After Transaction: Common Stock — 9,527 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 2,330 shares Restricted stock units granted on 2026-06-04
Grant price $0.00 per share Compensation grant, not open-market purchase
Holdings after grant 9,527 shares Total common stock directly held after transaction
Vesting date 2027 annual meeting 100% of RSUs vest at 2027 annual stockholder meeting
restricted stock units financial
"Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
annual meeting of stockholders financial
"100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders"
vesting financial
"subject to the Reporting Person's continued service through such vesting date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HOVSEPIAN RONALD W

(Last)(First)(Middle)
C/O PROCORE TECHNOLOGIES, INC.
6309 CARPINTERIA AVENUE

(Street)
CARPINTERIA CALIFORNIA 93013

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PROCORE TECHNOLOGIES, INC. [ PCOR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026A2,330(1)A$09,527D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date.
Remarks:
/s/ Benjamin C. Singer, Attorney-in-Fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PROCORE (PCOR) director Ronald Hovsepian report?

Ronald W. Hovsepian reported receiving 2,330 shares of PROCORE common stock through a restricted stock unit grant. This is a compensation-related award, not an open-market purchase or sale, and increases his directly held common stock position.

How many PROCORE (PCOR) shares did Ronald Hovsepian hold after this Form 4?

After the reported transaction, Ronald W. Hovsepian directly held 9,527 shares of PROCORE common stock. This figure includes the newly granted 2,330 restricted stock units that will settle into shares when they vest under the award terms.

What are the vesting terms of Ronald Hovsepian’s new PROCORE RSUs?

The 2,330 restricted stock units vest 100% on the date of PROCORE’s 2027 annual meeting of stockholders. Vesting can also occur immediately before that date if his board service ends then due to not being re-elected or not standing for re-election.

Was cash paid for Ronald Hovsepian’s PROCORE RSU grant on this Form 4?

No cash was paid for this transaction. The RSU grant is a stock-based compensation award with a reported price per share of $0.00, reflecting that it is granted rather than purchased in the open market.

Is Ronald Hovsepian’s PROCORE Form 4 transaction a buy or a sale?

The transaction is an acquisition via grant, reported under code A for "Grant, award, or other acquisition." It reflects a restricted stock unit compensation award, not an open-market buy or sell trade in PROCORE shares.